Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.1750
-0.0150 (-7.89%)
At close: Feb 4, 2026
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of 57.24 million as of February 4, 2026. Its market cap has increased by 134.68% in one year.
Market Cap
57.24M
Enterprise Value
56.86M
Revenue
3.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
Market Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has increased from 32.74M to 57.24M, an increase of 74.80%. That is a compound annual growth rate of 7.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 57.24M | 30.03% |
| Dec 31, 2025 | 44.02M | 78.41% |
| Dec 31, 2024 | 24.67M | -17.35% |
| Dec 29, 2023 | 29.85M | -86.11% |
| Dec 30, 2022 | 215.00M | -33.62% |
| Dec 31, 2021 | 323.86M | 83.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 961.60M |
| Healius | 678.93M |
| Australian Clinical Labs | 530.69M |
| Monash IVF Group | 276.64M |
| Microba Life Sciences | 52.37M |
| Cryosite | 51.74M |
| INOVIQ | 49.27M |
| BCAL Diagnostics | 42.33M |